Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Molecular Pharming: future targets and aspirations.
Paul M, van Dolleweerd C, Drake PM, Reljic R, Thangaraj H, Barbi T, Stylianou E, Pepponi I, Both L, Hehle V, Madeira L, Inchakalody V, Ho S, Guerra T, Ma JK. Paul M, et al. Among authors: inchakalody v. Hum Vaccin. 2011 Mar;7(3):375-82. doi: 10.4161/hv.7.3.14456. Epub 2011 Mar 1. Hum Vaccin. 2011. PMID: 21368584 Free PMC article. Review.
Circulating exosomal immuno-oncological checkpoints and cytokines are potential biomarkers to monitor tumor response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients.
Akbar S, Raza A, Mohsin R, Kanbour A, Qadri S, Parray A, Zar Gul AR, Philip A, Vijayakumar S, Merhi M, Hydrose S, Inchakalody VP, Al-Abdulla R, Abualainin W, Sirriya SA, Al-Bozom I, Uddin S, Khan OM, Mohamed Ibrahim MI, Al Homsi U, Dermime S. Akbar S, et al. Among authors: inchakalody vp. Front Immunol. 2023 Jan 18;13:1097117. doi: 10.3389/fimmu.2022.1097117. eCollection 2022. Front Immunol. 2023. PMID: 36741391 Free PMC article.
Persistence of spike-specific immune responses in BNT162b2-vaccinated donors and generation of rapid ex-vivo T cells expansion protocol for adoptive immunotherapy: A pilot study.
Mestiri S, Merhi M, Inchakalody VP, Taib N, Smatti MK, Ahmad F, Raza A, Ali FH, Hydrose S, Fernandes Q, Ansari AW, Sahir F, Al-Zaidan L, Jalis M, Ghoul M, Allahverdi N, Al Homsi MU, Uddin S, Jeremijenko AM, Nimir M, Abu-Raddad LJ, Abid FB, Zaqout A, Alfheid SR, Saqr HMH, Omrani AS, Hssain AA, Al Maslamani M, Yassine HM, Dermime S. Mestiri S, et al. Among authors: inchakalody vp. Front Immunol. 2023 Feb 2;14:1061255. doi: 10.3389/fimmu.2023.1061255. eCollection 2023. Front Immunol. 2023. PMID: 36817441 Free PMC article.
Neutralization of MERS coronavirus through a scalable nanoparticle vaccine.
Mohsen MO, Rothen D, Balke I, Martina B, Zeltina V, Inchakalody V, Gharailoo Z, Nasrallah G, Dermime S, Tars K, Vogel M, Zeltins A, Bachmann MF. Mohsen MO, et al. Among authors: inchakalody v. NPJ Vaccines. 2021 Aug 24;6(1):107. doi: 10.1038/s41541-021-00365-w. NPJ Vaccines. 2021. PMID: 34429427 Free PMC article.
24 results